The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.70
Bid: 28.10
Ask: 30.70
Change: 1.90 (6.60%)
Spread: 2.60 (9.253%)
Open: 28.10
High: 30.70
Low: 28.10
Prev. Close: 28.80
EKF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

7 Jun 2018 14:30

RNS Number : 6894Q
EKF Diagnostics Holdings PLC
07 June 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

EKF DIAGNOSTICS HOLDINGS PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Details of person subject to the notification obligation

Name

CANACCORD GENUITY GROUP INC

City and country of registered office (if applicable)

VANCOUVER, CANADA

4. Full name of shareholder(s) (if different from 3.)

Name

DISCRETIONARY CLIENTS

City and country of registered office (if applicable)

As above

5. Date on which the threshold was crossed or reached:

06 JUNE 2018

6. Date on which issuer notified (DD/MM/YYYY):

07 JUNE 2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

5.0356

5.0356

457,554,636

Position of previous notification (if

applicable)

4.3851

4.3851

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB0031509804

23,040,777

5.0356

SUBTOTAL 8. A

23,040,777

5.0356

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Physical or cash

settlement

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

X

 

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

Canaccord Genuity Group Inc.

5.0356

5.0356

 

Canaccord Genuity Wealth Group Holdings Limited

5.0356

5.0356

 

Canaccord Genuity Wealth Group Holdings (Jersey) Limited

5.0356

5.0356

 

Hargreave Hale Ltd

5.0315

5.0315

 

Canaccord Genuity Wealth Group Limited

0.0041

0.0041

 

Canaccord Genuity Wealth Limited

0.0041

0.0041

 

 

10. In case of proxy voting, please identify:

 

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional information

 

 

 

 

 

Place of completion

BLACKPOOL, ENGLAND

Date of completion

07 JUNE 2018

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUBUORWNANRAR
Date   Source Headline
4th Mar 20137:00 amRNSEstablishment of EKF Molecular & Acquisition
18th Jan 20137:00 amRNSPre-close Trading Update
21st Dec 20123:53 pmRNSDirectors' Exercise of Options
17th Dec 20127:00 amRNSHolding(s) in Company
27th Nov 20124:32 pmRNSHolding(s) in Company
9th Nov 20127:00 amRNSIssue of Equity
24th Sep 20127:00 amRNSHalf Yearly Report
5th Sep 20127:00 amRNSTrading Update
14th Aug 20127:00 amRNSNICE guidance on type 2 diabetes
10th Aug 20127:00 amRNSHemoCue settlement agreement
17th Jul 20127:00 amRNSLicensing agreement for kidney markers
16th Jul 20123:05 pmRNSHolding(s) in Company
16th Jul 20127:00 amRNSQuo-Lab CE marking & Commercial launch
12th Jul 20121:11 pmRNSHolding(s) in Company
28th Jun 20127:00 amRNSDirector's Share Options
26th Jun 201210:30 amRNSHolding(s) in Company
23rd May 20121:00 pmRNSResult of AGM
11th May 20127:00 amRNSUpdate on Disposal of IBL AG
20th Apr 201211:18 amRNSPublication of Annual Report & Notice of AGM
18th Apr 20124:50 pmRNSHolding(s) in Company
5th Apr 20127:00 amRNSDirectors' Exercise of Options
5th Apr 20127:00 amRNSChina Patent Grant
3rd Apr 20121:47 pmRNSHolding(s) in Company
27th Mar 20127:00 amRNSDisposal of International Brand Licensing AG
26th Mar 20128:18 amRNSAdviser Change of Name
21st Mar 20127:00 amRNSFinal Results
20th Mar 20127:00 amRNSAppointment of Group Head of Sales
16th Mar 20127:00 amRNSTrading Update & Notice of Final Results
8th Mar 20127:00 amRNSUS Patent Grant
6th Feb 20127:00 amRNSNew US contract win
30th Jan 20122:08 pmRNSHolding(s) in Company
19th Jan 20127:00 amRNSPre-Close Trading Update
30th Nov 20117:00 amRNSContract win
29th Nov 20117:00 amRNSUpdate on US market expansion
24th Oct 20115:53 pmRNSHolding(s) in Company
24th Oct 20115:51 pmRNSHolding(s) in Company
12th Oct 201112:42 pmRNSHolding(s) in Company
7th Oct 20113:44 pmRNSHolding(s) in Company
29th Sep 20115:14 pmRNSHolding(s) in Company
28th Sep 20117:01 amRNSDirectorate Change
28th Sep 20117:00 amRNSHalf Yearly Report
27th Sep 20117:00 amRNSChange of Adviser
23rd Sep 20111:26 pmRNSNotice of Results
6th Jul 20113:48 pmRNSResult of AGM
29th Jun 20119:45 amRNSDirectors' Dealings
22nd Jun 20117:00 amRNSHolding(s) in Company
20th Jun 201111:37 amRNSHolding(s) in Company
20th Jun 201111:35 amRNSHolding(s) in Company
17th Jun 20114:00 pmRNSHolding(s) in Company
16th Jun 20113:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.